Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Argus Health
UBS
Accenture
Queensland Health
Chinese Patent Office
McKesson
Cantor Fitzgerald
Colorcon

Generated: April 27, 2018

DrugPatentWatch Database Preview

NIPRIDE Drug Profile

« Back to Dashboard

Which patents cover Nipride, and when can generic versions of Nipride launch?

Nipride is a drug marketed by Roche and Exela Pharma Scs Llc and is included in two NDAs.

The generic ingredient in NIPRIDE is sodium nitroprusside. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Summary for NIPRIDE
Drug patent expirations by year for NIPRIDE

US Patents and Regulatory Information for NIPRIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche NIPRIDE sodium nitroprusside INJECTABLE;INJECTION 017546-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;IV (INFUSION) 209387-002 Dec 7, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Exela Pharma Scs Llc NIPRIDE RTU IN SODIUM CHLORIDE 0.9% sodium nitroprusside SOLUTION;IV (INFUSION) 209387-001 Mar 8, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
Cantor Fitzgerald
McKesson
Johnson and Johnson
Queensland Health
Mallinckrodt
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.